# DoD Reconstructive Transplant, Idea Discovery Award

Source: https://welltoldgrants.com/grants/ht942524rtrpida-dod-reconstructive-transplant-idea-discovery-award/  
Official notice: https://www.grants.gov/search-results-detail/355187

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 5 awards worth $2.5 million in total. Applications closed on October 23, 2024.

| Field | Value |
|---|---|
| Opportunity number | HT942524RTRPIDA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | October 23, 2024 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 5 |
| Total funding | $2.5 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The FY24 RTRP Idea Discovery Award is intended to support innovative, untested, high-risk/ potentially high-reward concepts, theories, paradigms, and/or methods relevant to reconstructive transplant. The outcome of research supported by this award should be the generation of robust data that can be used as a foundation for new avenues of scientific investigation. Important aspects of this award mechanism include: • Innovation: The proposed project should be novel and innovative. Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities. If the proposed project is building upon established research performed in solid tissue organs, there must be justification for how the proposed theory is novel. Research that is an incremental advance upon published data or a logical progression of an already established research project is not considered innovative and will not be considered for funding under this award mechanism. Important Note: Leveraging novel findings from solid organ transplant research for testing in a VCA setting is acceptable if the rationale and benefits for doing so are appropriately explained and justified. For example, it should be clear why the anticipated result might be different in VCA, or why it’s important to confirm the result is the same in VCA, or why repeating the study in a VCA setting could lead to new mechanistic insights or a better understanding of unique aspects of VCA. • Hypothesis and Rationale: The proposed research project should include a well-formulated testable hypothesis based on strong scientific rationale and study design. If a model system is included in the research, it should be appropriate for the study and applicable to VCA. • Preliminary Data: Inclusion of preliminary and/or published data that support the scientific rationale or evidence that the proposed work can be completed are required; however, the proposed work should be innovative and untested. • Impact: Applications must address at least one of the FY24 RTRP IDA Focus Areas. The anticipated outcome(s)/product(s), including material and/or knowledge products, should be clearly articulated, as should the anticipated long-term gains from this research trajectory.

## Questions people ask

### Is HT942524RTRPIDA still open?

No. It closed on October 23, 2024. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Reconstructive Transplant, Idea Discovery Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Reconstructive Transplant, Idea Discovery Award?

Closed October 23, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $2.5 million in total across about 5 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.